IP Library Granted Patent US 8,139,207
Granted Patent B2
US 8,139,207 · App. 13/210,347 · Granted Mar 20, 2012

In vitro determination of analyte levels within body fluids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,139,207
App. No.
13/210,347
Granted
Mar 20, 2012
Kind
B2
Abstract

A reagentless whole-blood analyte detection system that is capable of being deployed near a patient has a source capable of emitting a beam of radiation that includes a spectral band. The whole-blood system also has a detector in an optical path of the beam. The whole-blood system also has a housing that is configured to house the source and the detector. The whole-blood system also has a sample element that is situated in the optical path of the beam. The sample element has a sample cell and a sample cell wall that does not eliminate transmittance of the beam of radiation in the spectral band.

Claims (13)

1. An apparatus for determining the level of an analyte in a biological fluid sample from a patient, the apparatus comprising:

an analyte detection system configured to determine the level of at least one analyte in the biological fluid sample;

a sample extractor configured to withdraw the biological fluid sample through the skin of the patient; and

a disposable sample element configured to be used more than once before being discarded, the disposable sample element comprising:

a sample cell;

a sample supply passage in fluid communication with the sample cell; and

a container configured to store discarded biohazardous material;

wherein the sample cell is configured to:

receive at least a portion of the first component of the biological fluid sample through the sample supply passage; and

hold the portion of the first component of the biological fluid sample between a first sample cell wall and a second sample cell wall of the sample cell while the analyte detection system analyzes the portion of the first component of the biological fluid sample to determine the level of the at least one analyte in the biological fluid sample.

2. The apparatus of claim 1 , wherein the apparatus comprises a fluid separator configured to separate a first component of the biological fluid sample from other components thereof.

3. The apparatus of claim 1 , wherein the sample cell comprises a reagentless sample cell.

4. The apparatus of claim 1 , further comprising a blood acquisition system configured to draw the biological fluid sample from the patient, wherein the sample supply passage is configured to conduct the biological fluid sample into the sample cell.

Assignments (2)
AMENDED AND RESTATED IP SECURITY AGREEMENT Recorded Feb 28, 2018
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 045469/0948 →
SECURITY AGREEMENT Recorded Dec 13, 2013
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 031815/0377 →